Universal Ibogaine (TSXV:IBO) Change In Receivables : C$-0.14 Mil (TTM As of Jan. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Universal Ibogaine Change In Receivables?

Universal Ibogaine's change in receivables for the quarter that ended in Jan. 2024 was C$0.03 Mil. It means Universal Ibogaine's Accounts Receivable declined by C$0.03 Mil from Oct. 2023 to Jan. 2024 .

Universal Ibogaine's change in receivables for the fiscal year that ended in Jul. 2023 was C$0.16 Mil. It means Universal Ibogaine's Accounts Receivable declined by C$0.16 Mil from Jul. 2022 to Jul. 2023 .

Universal Ibogaine's Accounts Receivable for the quarter that ended in Jan. 2024 was C$0.22 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Universal Ibogaine's Days Sales Outstanding for the three months ended in Jan. 2024 was 34.24.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Universal Ibogaine's liquidation value for the three months ended in Jan. 2024 was C$-3.32 Mil.

Universal Ibogaine Change In Receivables Historical Data

The historical data trend for Universal Ibogaine's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Universal Ibogaine Change In Receivables Chart

Universal Ibogaine Annual Data

Trend

Mar17

Mar18

Mar19

Mar20

Mar21

Jul22

Jul23

Change In Receivables

Get a 7-Day Free Trial

0.02

-0.01

0.16

Universal Ibogaine Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
Change In Receivables	Get a 7-Day Free Trial															-	-	-	-0.17	0.03

Universal Ibogaine Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.14 Mil.

Universal Ibogaine (TSXV:IBO) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Universal Ibogaine's Days Sales Outstanding for the quarter that ended in Jan. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	0.221	/	0.589	*	91
=	34.24

2. In Ben Graham's calculation of liquidation value, Universal Ibogaine's accounts receivable are only considered to be worth 75% of book value:

Universal Ibogaine's liquidation value for the quarter that ended in Jan. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	0.365	-	3.852	+	0.75 * 0.221	+	0.5 * 0
=	-3.32

Universal Ibogaine Change In Receivables Related Terms

Thank you for viewing the detailed overview of Universal Ibogaine's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Universal Ibogaine (TSXV:IBO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Universal Ibogaine Inc (TSXV:IBO) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

IBOGF:USA JC4:Germany

Address

400 3rd Avenue South west, Suite 1470, Calgary, AB, CAN, T2P 4H2

Website

https://www.universalibogaine.com

Universal Ibogaine Inc develops a platform of addiction treatment clinics, which use ibogaine as a primary modality for the interruption and ideally cessation of addictions to primarily opioids such as oxycodone, heroin, fentanyl, as well as alcohol, cocaine, and other stimulants. It runs addiction clinics it has a research partner clinic in Mexico.

Executives

Ian Rabb

Senior Officer

Universal Ibogaine (TSXV:IBO) Headlines

No Headlines